Acute lymphoblastic leukemia of childhood: results of combination therapy.
D001932:Brain Neoplasms / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006562:Herpes Zoster; D014645:Herpesvirus 3, Human; D006801:Humans; D007223:Infant; D007239:Infections / Q000150:complications; D007938:Leukemia / Q000517:prevention & control; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011024:Pneumonia, Viral / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012871:Skin Diseases / Q000150:complications; D014750:Vincristine / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control
D014765:Viral Vaccines; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate